The study is the first in vivo human trial of a CRISPR-based therapy to be performed in the US, and has the potential to Read more
Centre for Eye Health completes My Health Record integration
With nine in 10 Australians now assigned a My Health Record, the change is expected to affect a large proportion of the CFEH’s patients.“Secure Read more
New BHVI course covers the business of myopia
Beginning 20 August, The Business of Myopia forms the third component of BHVI’s Myopia Education Program, and will provide participants with the practical knowledge Read more
Sudden departure prompts leadership change at Ellex
Wallace recently informed the board of his decision to step away from the more than $320,000-per-year position, with the company allowing the resignation to Read more
Optometry Australia holds firm on “confidential” membership number
CEO Ms Lyn Brodie continues to keep the organisation’s exact mbership figure off the public record, and requests for specific mbership figures to OA Read more
Taking the plunge into dry eye care
For a disease that once struggled for legitimacy, the rapid evolution of dry eye care in Australia has been rarkable.Now a well-established subspecialty, only Read more
Low-cost OCT system could improve access to scans
The team at Duke University behind the project have engineered the device to be 15x lighter and smaller than conventional OCT systs, and anticipate Read more
Ancient glass blowing method used to produce OCT lenses
The technique, developed by the FTO-ST Institute in France, was recently described in The Optical Society journal Optics Letters. It is based on the Read more
Autofocal’ glasses adjust based on where a user is looking
The prototype glasses use eye-tracking technology to automatically control a pair of autofocus lenses. By triangulating using each eye’s line of sight, the glasses Read more
Recruitment drive for world-first viral conjunctivitis therapy
The RUBY Trial is being conducted in seven sites across the country, and will evaluate the safety and efficacy of Okogen’s lead drug candidate Read more